Eisai preps for launch with insomnia med Dayvigo after buying out Purdue

Eisai preps for launch with insomnia med Dayvigo after buying out Purdue

Source: 
Fierce Pharma
snippet: 
Once partners with the now-embattled Purdue on an insomnia treatment, Eisai bought a full stake in the drug earlier this year—taking on its full development and marketing costs, too. Now, with an FDA approval in hand, Eisai is scaling up to support that drug's pending launch.